Radiation oncologists involved in the treatment of haematological malignancies.

Course Director

Lena Specht, Clinical Oncologist, Rigshospitalet, Copenhagen (DK)

Co-Course Director

Joachim Yahalom, Radiation Oncologist, Memorial Sloan-Kettering Cancer Centre, New York (USA)

Teachers

• Berthe Aleman, Radiation Oncologist, Netherlands Cancer Institute, Amsterdam (NL)
• Anne Kiil Berthelsen, Radiologist, Rigshospitalet, Copenhagen (DK)
• Andreas Engert, Medical Oncologist/Haematologist, University of Cologne, Cologne (DE)
• Andrew Davies, Medical Oncologist, Southampton University Hospital NHS Trust, Southampton (UK)
• Tim Illidge, Clinical Oncologist, Christie Hospital, Manchester (UK)
• George Mikhaeel, Radiation Oncologist, Guy’s & St Thomas’ Hospital, London (UK)
• Umberto Ricardi, Radiation Oncologist, University of Turin, Turin (IT)

Guest lecturer

Bouthaina Dabaja, Radiation Oncologist, MD Anderson Cancer Centre, Houston, Texas (USA)

Contouring administrator

Angela Botticella, Radiation Oncologist, Institut Gustave Roussy, Villejuif (FR)

The aim of this course is to:

• Enable radiation oncologists to participate in the modern multidisciplinary management of haematological malignancies
• Administer radiotherapy to these diseases according to modern principles, using up-todate technology to achieve maximum cure rates while at the same time minimising the risk of long-term complications.

Learning Outcomes

By the end of this course participants should be able to:

• Design strategies for the multimodality treatment of haematological malignancies
• Apply modern principles for radiotherapy in the multimodality setting
• Define target volumes and prescribe radiation doses and fractionation schedules appropriate for different haematological malignancies
• Apply and evaluate different treatment techniques depending on disease localisations and risks of normal tissue complications.

Course Content

• Role of radiation oncology in the multimodality treatment of lymphomas
• General principles of treatment: radiotherapy (incl. protons for lymphomas), chemotherapy, immunotherapy (incl. CAR T-cell therapy), radioimmunotherapy, combined modality treatment and long term toxicity
• Imaging for radiotherapy
• Hodgkin lymphoma: classic and lymphocyte predominance; early and advanced stages, recurrence; radiotherapy volumes, doses and techniques
• Indolent nodal non-Hodgkin lymphoma: early and advanced stages, recurrence; radiotherapy volumes, doses and techniques
• Aggressive nodal non-Hodgkin lymphoma: early and advanced stages, recurrence; radiotherapy volumes, doses and techniques
• Extranodal lymphomas: characteristics, role of radiotherapy, volumes, doses and techniques
• Other indications for radiotherapy: myeloma, granulocytic sarcoma, hypersplenism, total body irradiation as conditioning for transplant: volumes, doses and techniques.

Prerequisites

Before commencing this course participants should:

• Be a radiation oncologist with some experience
• Have an interest in and knowledge of the spectrum of haematological malignancies
• Read the publications mentioned below
• Have completed the exercise on the two contouring cases sent out in advance.

Please find the programme here.

Membership

ESTRO members can order products at substantially reduced prices. To benefit from the member registration rate, you must subscribe for the ESTRO membership 2023 BEFORE registering to the course. To become an ESTRO member, benefit from the member registration rate and discover the many other member advantages, please visit the membership page.

Fees

Reduced fees

Members from emerging countries may register at a preferential rate of 250 Euro. Emerging country fee applies to individuals from low-income and lower-middle-income economies according to the World Bank listing here. Please send a mail to education@estro.org to request this rate.

World Bank Country and Lending Groups – World Bank Data Help Desk

Cancellation

Cancellation is NOT possible after payment.